Medical Cannabis at Work UK: New EAT Ruling on Safety-Critical Jobs and Disability Rights

A Landmark Moment for Medical Cannabis Patients in UK Employment Law

The Employment Appeal Tribunal (EAT) has considered a significant case involving prescribed medical cannabis and disability discrimination — specifically in the context of safety-critical rail work. The May 2026 ruling has implications far beyond the rail sector, touching every UK employer with safety-sensitive roles and every employee who holds a medical cannabis prescription.

What Was the Case About?

The case centred on a rail worker who held a valid prescription for medical cannabis to manage a chronic pain condition recognised as a disability under the Equality Act 2010. The employer argued that the prescription created an unacceptable safety risk in a safety-critical role, and took action against the employee. The worker argued this constituted disability discrimination — that their prescribing doctor, not their employer, was best placed to assess risk.

The EAT’s consideration of the case marks the first time a senior UK employment tribunal has been asked to directly address prescribed cannabis use in a safety-critical context. The legal question cuts to the heart of how employers should handle a growing population of employees with legitimate, legal prescriptions for cannabis-based medicines.

What Does This Mean for Employees?

If you hold a medical cannabis prescription and work in a safety-sensitive role — transport, healthcare, construction, manufacturing — the emerging legal picture suggests:

  • You have a right to disclose your prescription without automatic dismissal
  • Your employer must conduct an individual assessment — blanket bans on prescribed medications may breach the Equality Act
  • Medical evidence matters — a letter from your prescribing specialist outlining your fitness for work is essential
  • Occupational health referral — a reasonable employer should refer you to OH rather than dismissing immediately

What Does This Mean for Employers?

The EAT case underlines that employers cannot treat prescribed cannabis the same as illicit drug use. The legal obligations under the Equality Act require:

  1. Individual risk assessment for each employee with a prescription
  2. Consultation with the employee and their treating clinician
  3. Consideration of reasonable adjustments before any adverse action
  4. Clear, written policies that distinguish between prescribed and unprescribed use

With the number of UK medical cannabis patients estimated to exceed 100,000 by 2026, this is no longer a niche issue. HR teams and occupational health professionals need updated guidance now.

The Drug Testing Problem

A core challenge in safety-critical settings is drug testing. Standard urine or saliva tests for THC cannot distinguish between someone who used cannabis recreationally yesterday and someone who took prescribed cannabis oil a week ago. THC metabolites can remain detectable for 2–4 weeks in regular users.

For medical cannabis patients, this creates a serious problem: a positive test does not prove impairment. Leading occupational health bodies are now calling for impairment-based testing rather than presence-based testing — but adoption is slow.

Practical Steps for Medical Cannabis Patients at Work

  • Inform your employer in writing that you hold a valid prescription (this triggers Equality Act protections)
  • Request your prescribing clinic to provide a letter confirming your treatment and any fitness-for-work guidance
  • Ask for an occupational health referral rather than accepting an immediate employment decision
  • Keep records of all communications about your prescription and your role

For more on the legal framework around medical cannabis in the UK, see our full guide to UK cannabis law and our FAQ on UK legal questions answered. Our cannabis and insurance guide covers related employment and liability considerations.

Looking Ahead

The EAT’s treatment of this case is being watched closely by employment law specialists and patient advocacy groups. A clear ruling in favour of the employee would represent a significant strengthening of rights for prescribed cannabis patients — and a significant shift in how UK workplaces must approach this issue in 2026 and beyond.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Medical cannabis is a prescription-only medicine in the UK. Always consult a qualified healthcare professional. CannaZen is an information platform, not a medical provider.

Related Posts